Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy
1. FFAI invested $41 million in Qualigen Therapeutics for crypto ventures. 2. FFAI now holds 55% stake in QLGN after investment completion. 3. YT Jia, FF's Co-CEO, committed 7% stake for two years. 4. Investment aligns with FF's strategy connecting EAI and crypto sectors. 5. FF aims to create value for stockholders and token holders.